Cargando…
Pharmacokinetics of intravitreal antibiotics in endophthalmitis
Intravitreal antibiotics are the mainstay of treatment in the management of infectious endophthalmitis. Basic knowledge of the commonly used intravitreal antibiotics, which includes their pharmacokinetics, half-life, duration of action and clearance, is essential for elimination of intraocular infec...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306439/ https://www.ncbi.nlm.nih.gov/pubmed/25667683 http://dx.doi.org/10.1186/s12348-014-0022-z |
_version_ | 1782354326681812992 |
---|---|
author | Radhika, Medikonda Mithal, Kopal Bawdekar, Abhishek Dave, Vivek Jindal, Animesh Relhan, Nidhi Albini, Thomas Pathengay, Avinash Flynn, Harry W |
author_facet | Radhika, Medikonda Mithal, Kopal Bawdekar, Abhishek Dave, Vivek Jindal, Animesh Relhan, Nidhi Albini, Thomas Pathengay, Avinash Flynn, Harry W |
author_sort | Radhika, Medikonda |
collection | PubMed |
description | Intravitreal antibiotics are the mainstay of treatment in the management of infectious endophthalmitis. Basic knowledge of the commonly used intravitreal antibiotics, which includes their pharmacokinetics, half-life, duration of action and clearance, is essential for elimination of intraocular infection without any iatrogenic adverse effect to the ocular tissue. Various drugs have been studied over the past century to achieve this goal. We performed a comprehensive review of the antibiotics which have been used for intravitreal route and the pharmacokinetic factors influencing the drug delivery and safety profile of these antibiotics. Using online resources like PubMed and Google Scholar, articles were reviewed. The articles were confined to the English language only. We present a broad overview of pharmacokinetic concepts fundamental for use of intravitreal antibiotics in endophthalmitis along with a tabulated compendium of the intravitreal antibiotics using available literature. Recent advances for increasing bioavailability of antibiotics to the posterior segment with the development of controlled drug delivery devices are also described. |
format | Online Article Text |
id | pubmed-4306439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer |
record_format | MEDLINE/PubMed |
spelling | pubmed-43064392015-02-09 Pharmacokinetics of intravitreal antibiotics in endophthalmitis Radhika, Medikonda Mithal, Kopal Bawdekar, Abhishek Dave, Vivek Jindal, Animesh Relhan, Nidhi Albini, Thomas Pathengay, Avinash Flynn, Harry W J Ophthalmic Inflamm Infect Review Intravitreal antibiotics are the mainstay of treatment in the management of infectious endophthalmitis. Basic knowledge of the commonly used intravitreal antibiotics, which includes their pharmacokinetics, half-life, duration of action and clearance, is essential for elimination of intraocular infection without any iatrogenic adverse effect to the ocular tissue. Various drugs have been studied over the past century to achieve this goal. We performed a comprehensive review of the antibiotics which have been used for intravitreal route and the pharmacokinetic factors influencing the drug delivery and safety profile of these antibiotics. Using online resources like PubMed and Google Scholar, articles were reviewed. The articles were confined to the English language only. We present a broad overview of pharmacokinetic concepts fundamental for use of intravitreal antibiotics in endophthalmitis along with a tabulated compendium of the intravitreal antibiotics using available literature. Recent advances for increasing bioavailability of antibiotics to the posterior segment with the development of controlled drug delivery devices are also described. Springer 2014-09-10 /pmc/articles/PMC4306439/ /pubmed/25667683 http://dx.doi.org/10.1186/s12348-014-0022-z Text en Copyright © 2014 Mediknoda et al.; licensee Springer. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Radhika, Medikonda Mithal, Kopal Bawdekar, Abhishek Dave, Vivek Jindal, Animesh Relhan, Nidhi Albini, Thomas Pathengay, Avinash Flynn, Harry W Pharmacokinetics of intravitreal antibiotics in endophthalmitis |
title | Pharmacokinetics of intravitreal antibiotics in endophthalmitis |
title_full | Pharmacokinetics of intravitreal antibiotics in endophthalmitis |
title_fullStr | Pharmacokinetics of intravitreal antibiotics in endophthalmitis |
title_full_unstemmed | Pharmacokinetics of intravitreal antibiotics in endophthalmitis |
title_short | Pharmacokinetics of intravitreal antibiotics in endophthalmitis |
title_sort | pharmacokinetics of intravitreal antibiotics in endophthalmitis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306439/ https://www.ncbi.nlm.nih.gov/pubmed/25667683 http://dx.doi.org/10.1186/s12348-014-0022-z |
work_keys_str_mv | AT radhikamedikonda pharmacokineticsofintravitrealantibioticsinendophthalmitis AT mithalkopal pharmacokineticsofintravitrealantibioticsinendophthalmitis AT bawdekarabhishek pharmacokineticsofintravitrealantibioticsinendophthalmitis AT davevivek pharmacokineticsofintravitrealantibioticsinendophthalmitis AT jindalanimesh pharmacokineticsofintravitrealantibioticsinendophthalmitis AT relhannidhi pharmacokineticsofintravitrealantibioticsinendophthalmitis AT albinithomas pharmacokineticsofintravitrealantibioticsinendophthalmitis AT pathengayavinash pharmacokineticsofintravitrealantibioticsinendophthalmitis AT flynnharryw pharmacokineticsofintravitrealantibioticsinendophthalmitis |